Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.
This P, de la Rochefordière A, Savignoni A, Falcou MC, Tardivon A, Thibault F, Alran S, Fourchotte V, Fitoussi A, Couturaud B, Dolbeault S, Salmon RJ, Sigal-Zafrani B, Asselain B, Stoppa-Lyonnet D; Institut Curie Breast and Ovarian Cancer Risk Study Group. This P, et al. Among authors: asselain b. Fam Cancer. 2012 Sep;11(3):473-82. doi: 10.1007/s10689-012-9539-1. Fam Cancer. 2012. PMID: 22711610 Clinical Trial.
Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study.
Caux-Moncoutier V, Pagès-Berhouet S, Michaux D, Asselain B, Castéra L, De Pauw A, Buecher B, Gauthier-Villars M, Stoppa-Lyonnet D, Houdayer C. Caux-Moncoutier V, et al. Among authors: asselain b. Eur J Hum Genet. 2009 Nov;17(11):1471-80. doi: 10.1038/ejhg.2009.89. Epub 2009 May 27. Eur J Hum Genet. 2009. PMID: 19471317 Free PMC article.
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.
Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A. Kirova YM, et al. Among authors: asselain b. Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033769 Review.
Reasons of not having breast reconstruction: a historical cohort of 1937 breast cancer patients undergoing mastectomy.
Héquet D, Zarca K, Dolbeault S, Couturaud B, Ngô C, Fourchotte V, De La Rochefordière A, Féron JG, Fitoussi A, Bélichard C, Reyal F, Laki F, Hajage D, Sigal B, Asselain B, Alran S; Institut Curie Breast Cancer Group, Roman Rouzier. Héquet D, et al. Among authors: asselain b. Springerplus. 2013 Jul 18;2:325. doi: 10.1186/2193-1801-2-325. eCollection 2013. Springerplus. 2013. PMID: 23961399 Free PMC article.
Quality of life in a randomized control trial? Comments concerning MA 17.
This P, de la Rochefordière A, Bredart A, Asselain B, Poinsot R, Dolbeault S, Sigal-Zafrani B. This P, et al. Among authors: asselain b. J Clin Oncol. 2006 Aug 20;24(24):4038; author reply 4038-9. doi: 10.1200/JCO.2005.05.1987. J Clin Oncol. 2006. PMID: 16921063 No abstract available.
384 results